Official Publications Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 429.82 USD | +1.13% |
|
+1.39% | -5.19% |
| 05-06 | Vertex Pharmaceuticals Incorporated Signs Reimbursement Agreement for Casgevy in Germany | CI |
| 05-05 | Vertex Pharmaceuticals Insider Sold Shares Worth $469,222, According to a Recent SEC Filing | MT |
Official Publications
| 02-12 | SEC Filing 10K | CO |
| 02-11 | SEC Filing 8K | CO |
| 02-11 | Slide show results | CO |
| 02-11 | Annual results | CO |
| 11-02 | SEC Filing 8K | CO |
| 11-02 | Slide show Q3 | CO |
| 11-02 | 3rd quarter results | CO |
| 02/10/25 | SEC Filing 10Q-3 | CO |
| 03/08/25 | Slide show half-year results | CO |
| 03/08/25 | 1st-half-year results | CO |
| 03/08/25 | SEC Filing 8K | CO |
| 13/05/25 | Minutes of the general assembly | CO |
| 13/05/25 | SEC Filing 13G | CO |
| 04/05/25 | SEC Filing 10Q-1 | CO |
| 04/05/25 | Slide show Q1 | CO |
| 04/05/25 | 1st quarter results | CO |
| 04/05/25 | SEC Filing 8K | CO |
| 12/02/25 | SEC Filing 10K | CO |
| 09/02/25 | Slide show results | CO |
| 09/02/25 | Annual results | CO |
| 09/02/25 | SEC Filing 8K | CO |
| 30/12/24 | Proxy Statments | CO |
| 04/11/24 | SEC Filing 10Q-3 | CO |
| 03/11/24 | Slide show Q3 | CO |
| 03/11/24 | 3rd quarter results | CO |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Official Publications
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















